ClinicalTrials.gg
CompletedNCT03437343EOS-PTHUpdated Feb 19, 2018

Leg Length and Quality of Life After Total Hip Arthroplasty

An observational study in Total Hip Arthroplasty, sponsored by Assistance Publique - Hôpitaux de Paris. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-02-19.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
185
Ages
18 Years and older
Sex
All
01

Study summary

This study used 3D reconstructions from the EOS biplanar radiographic imaging system to perform leg length measurements before and after THA (Total hip arthroplasty) on all included THA patients from 2015 to evaluate surgeon performance in restoring lower limb length after THA and the relationships between the quality of life, estimated by the HOOS score (Hip disability and osteoarthritis outcome score), and the anatomy of the new hip in standing position.

Read the detailed description

The study was conducted in patients who underwent a total hip arthroplasty in Lariboisiere Hospital, Paris, France, during the year 2015.

This retrospective study used 3D reconstructions from the EOS biplanar radiographic imaging system (EOS imaging, Paris, France) to perform leg length measurements before and after THA on all included THA patients from 2015 to evaluate surgeon performance in restoring lower limb length after THA. Included patients either had hip osteoarthritis or femoral head osteonecrosis. Patients were excluded if they were undergoing revision surgery, or had a contralateral THA or total knee.

The performance of the surgeons was judged using the Cumulative Sum control chart (CUSUM) method.

Our objective was to study surgeon performance, measured by their ability to restore the initial preoperative length of the operated leg or to equalize the length of the two legs, and evaluate the relationships between the quality of life, estimated by the HOOS score, and the anatomy of the new hip in standing position using the EOS imaging system.

02

Conditions studied

  • Total Hip Arthroplasty

Browse trials for

Keywords

  • EOS
  • total hip arthroplasty
  • performance of surgeons
  • leg length discrepancy
  • HOOS
03

In context

Leg Length Inequality

30 studies on the registry are indexed under Leg Length Inequality; 2 are open to participants now.

This study's enrollment of 185 is above the median of 90 across 11 observational studies indexed under Leg Length Inequality.

Browse Leg Length Inequality studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,592 studies on the registry; 1,033 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study was conducted in patients who underwent a total hip arthroplasty in Lariboisiere Hospital, Paris, France, during the year 2015.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • unilateral total hip replacement for osteoarthritis or avascular necrosis healthy contralateral hip
  • age over 18 years
  • to participate in the study
  • radiographs obtained after total hip replacement using the EOS imaging system, filled HOOS form
  • clinical follow-up of 12 months at least

Exclusion criteria

Exclusion Criteria:

  • past history of contralateral hip replacement
  • ipsi or contralateral knee replacement
  • hip arthroplasty performed using a Kerboull cross
  • post-operative complications such as infection
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
185 participants (actual)
Patient registry
No

Interventions

  • ProcedureHip arthroplasty
06

What researchers measure

Primary outcomes

  1. Change in anatomic lower limb length measurements between preoperative and postoperative measurements

    Time frame: preoperative measurements (up to 1 year before surgery) and postoperative measurements (at 1 month after surgery)

Secondary outcomes

  1. Change in flessum/recurvatum/HKS angle (hip knee shaft ) measurements, between preoperative and postoperative measurements

    Time frame: preoperative measurements (up to 1 year before surgery) and postoperative measurements (at 1 month after surgery)

  2. HOOS score (Hip disability and osteoarthritis outcome score)

    The outcome score consists of 40 items assessing 5 subscales. Pain (P) includes 10 items with a total score of 40 points, Symptoms (S) includes 5 items with a total score of 20, Activity limitations daily living (ADL) includes 17 items with a total score of 68 and finally Function in sport and recreation (SP) and hip related quality of life both include 4 items with a total score of 16 each. To answer the questions, standardized answer options are given with scores from 0 to 4 (no, mild, moderate, severe and extreme). To interpret the score, the outcome measure is transformed in a worst to best scale from 0 to 100, with 100 indicating no symptoms and 0 indicating extreme symptoms. To calculate the total HOOS score the subscales need to be summed up, using following formula for all dimension. 100 - \[(patient's score of the subscale x 100)/(total score of the subscale)\]

    Time frame: 24 months after surgery

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2015 to primary completion in May 2017, 28 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 2, 2018
First posted
Feb 19, 2018
StartActual
Jan 1, 2015
Primary completionActual
May 31, 2017
CompletionActual
May 31, 2017
Last update
Feb 19, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03437343
Collaborators
Région Ile de France, France
Responsible party
Sponsor
First posted
Feb 19, 2018
Start date
Jan 1, 2015
Primary completion
May 31, 2017
Completion
May 31, 2017
Last update
Feb 19, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion